Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response – The Wall Street Journal
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the companies currently available vaccine in a study, they said.
A mo… [read more]
